NYSE:PMC Pharmerica (PMC) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PMC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume283,015 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pharmerica alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Pharmerica Stock (NYSE:PMC)PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.Read More Ad Whats On FinancePutin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy PMC Stock News HeadlinesMarch 30, 2024 | msn.comMedicine shortage hits TB elimination programme in PuneNovember 22, 2023 | msn.comFrom next month, PMC hospitals, maternity homes to get generic medicine storesApril 23, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.October 6, 2023 | bizjournals.comDavenport Extreme Pools & Spas owner and spouse charged with fraud, theftMay 25, 2023 | thestreet.comPharmerica Stock Falls On Unusually High Volume (PMC)April 20, 2023 | health.usnews.comActivities of Daily Living for SeniorsFebruary 24, 2023 | forbes.comGolden LivingJanuary 17, 2023 | marketwatch.comGas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028April 23, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? November 10, 2022 | marketwatch.comGas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028July 15, 2022 | msn.com9 Medford Residents To Participate In 2022 Pan-Mass ChallengeJanuary 21, 2022 | thestreet.comCVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7BDecember 8, 2021 | msn.comView | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiouslySee More Headlines Receive PMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharmerica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2017Today4/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Distributors Current SymbolNYSE:PMC CUSIP71714F10 CIK1388195 Webwww.pharmerica.com Phone+1-502-6277000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesGeoffrey G. Meyers (Age 72)Independent Chairman of the Board Gregory S. Weishar (Age 62)Chief Executive Officer, Director Suresh Vishnubhatla (Age 48)Executive Vice President - Long-term Care Operations Berard E. Tomassetti (Age 61)Senior Vice President, Chief Accounting Officer Thomas A. Caneris (Age 54)Senior Vice President, General Counsel, Secretary Robert A. McKay (Age 55)Senior Vice President - Purchasing and Trade Relations Frank E. Collins Esq. (Age 63)Independent Director W. Robert Robert Dahl Jr. (Age 60)Independent Director Marjorie W. Dorr (Age 55)Independent Director Patrick G. LePore (Age 62)Independent Director More Executives PMC Stock Analysis - Frequently Asked Questions How were Pharmerica's earnings last quarter? Pharmerica Co. (NYSE:PMC) issued its quarterly earnings results on Thursday, November, 9th. The company reported $0.46 earnings per share for the quarter, missing analysts' consensus estimates of $0.49 by $0.03. The business had revenue of $595.10 million for the quarter, compared to analysts' expectations of $596.80 million. What other stocks do shareholders of Pharmerica own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pharmerica investors own include Capitol Federal Financial (CFFN), Depomed (DEPO), Inovio Pharmaceuticals (INO), Bioblast Pharma (ORPN), Tesla (TSLA), Caterpillar (CAT), Gilead Sciences (GILD) and Horizon Therapeutics Public (HZNP). This page (NYSE:PMC) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmerica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
